Preethi Gunaratne to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Preethi Gunaratne has written about Drug Resistance, Neoplasm.
Connection Strength
0.216
-
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors. Cancer. 2019 07 15; 125(14):2409-2422.
Score: 0.154
-
?Np63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer. Cancer Cell. 2016 06 13; 29(6):874-888.
Score: 0.032
-
Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma. Nucl Recept Signal. 2015; 13:e006.
Score: 0.031